Kim So Ra, Lee Yong-Ho, Lee Sang-Guk, Kang Eun Seok, Cha Bong-Soo, Lee Byung-Wan
Division of Endocrinology and Metabolism, Department of Internal Medicine, Graduate School, Yonsei University College of Medicine, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.
Severance Hospital, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.
Cardiovasc Diabetol. 2017 Jan 26;16(1):16. doi: 10.1186/s12933-017-0497-7.
To determine the association between urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubulopathy, and carotid intima-media thickness (IMT) and plaques in patients with type 2 diabetes mellitus (T2D) and to compare the predictive value of NAG versus albuminuria, a marker of renal glomerulopathy.
A total of 343 participants were enrolled in this retrospective cross-sectional study. We recruited participants with T2D who were tested for blood glucose parameters, urinary NAG, and urinary albumin-to-creatinine ratio (ACR) and had been checked for carotid ultrasonography.
We classified participants into a below-median urinary NAG group (Group I; n = 172) or an above-median group (Group II; n = 171). Mean, maximum, and mean of maximum carotid IMT and the proportion of patients with carotid plaques were significantly higher in Group II compared with Group I. In multiple linear regression analyses, high urinary NAG (Group II) was significantly associated with carotid IMT, independently of urinary ACR and other confounding factors. In terms of carotid plaques, both urinary NAG and ACR were significantly higher in participants with carotid plaques than in those without carotid plaques. After adjustment for confounding factors, both urinary NAG and ACR were significantly associated with the presence of carotid plaques.
Elevated urinary NAG, a marker of renal tubular damage, was related to increased carotid IMT and the presence of carotid plaques in patients with T2D. Urinary NAG may be a more sensitive biomarker than urinary albumin for early detection of atherosclerosis.
确定2型糖尿病(T2D)患者中肾小管病变标志物尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)与颈动脉内膜中层厚度(IMT)及斑块之间的关联,并比较NAG与肾小球病变标志物蛋白尿的预测价值。
本回顾性横断面研究共纳入343名参与者。我们招募了T2D患者,对其进行血糖参数、尿NAG及尿白蛋白肌酐比值(ACR)检测,并进行颈动脉超声检查。
我们将参与者分为尿NAG低于中位数组(I组;n = 172)和高于中位数组(II组;n = 171)。与I组相比,II组的平均、最大及最大颈动脉IMT均值以及颈动脉斑块患者比例显著更高。在多元线性回归分析中,高尿NAG(II组)与颈动脉IMT显著相关,独立于尿ACR及其他混杂因素。就颈动脉斑块而言,有颈动脉斑块的参与者尿NAG和ACR均显著高于无颈动脉斑块者。在调整混杂因素后,尿NAG和ACR均与颈动脉斑块的存在显著相关。
尿NAG升高作为肾小管损伤的标志物,与T2D患者颈动脉IMT增加及颈动脉斑块的存在有关。尿NAG可能是比尿白蛋白更敏感的早期检测动脉粥样硬化的生物标志物。